Is a cure for hemophilia within reach?

 That is the question now being considered in light of a new research article in the New England Journal of Medicine in which a new gene therapy drug was given to men with hemophilia B.  After receiving the new drug, the patients were able to stop using clotting factors to treat their hemophilia.  Patients rates of bleeding also fell – from about 11 bleeding events per year to less than one bleeding event per year.  Learn more about the research here:

Explore genetics topics via the Genetics Journal Club and Himmelfarb Library’s genetics collection by checking out:

This entry was posted in E-Texts, Health news, Journals. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s